KIDS
ORTHOPEDIATRICS CORP
Next earnings Aug 3, 2026 (after close) · consensus $-0.31 EPS, $69.6M rev
Last earnings +2.9% on 2026-04-30
$20.30
▲ +3.47%$20.30▲ +0.05%
over 1Y
L $14.64EODHDH $23.68
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.5%
1W+11.8%
1M+15.7%
3M+30.8%
YTD+15.6%
1Y+0.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 15 analysts
Buy
Revenue grew 15.4% YoY; but unprofitable (net margin -16.8%).
ORTHOPEDIATRICS CORP shows $236M in FY2025 revenue (+15.4% YoY), a -16.8% net margin, and -11.4% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $98.0M | $122M | $149M | $205M | $236M |
| Gross profit | $73.4M | $90.7M | $111M | $149M | $173M |
| Operating income | -$18.0M | -$25.4M | -$26.8M | -$35.0M | -$39.2M |
| Net income | -$16.3M | $1.26M | -$21.0M | -$37.8M | -$39.6M |
| Diluted EPS | -$0.84 | $0.06 | -$0.92 | -$1.64 | -$1.69 |
| Net margin | -16.6% | 1.0% | -14.1% | -18.5% | -16.8% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$595M
EV / EBITDA—
EV / Sales2.5
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-7.7%
FCF yield-3.1%
Quality & risk
ROIC (est.)-6.9%
Free cash flow-$16.0M
Total debt$102M
Net cash-$82.1M
Altman Z-Score1.85 grey
Piotroski F-Score4/9
Capital returns
Buyback yield—
Dividend yield (est.)0.0%
Shareholder yield0.0%
Shares Δ YoY+4.1%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRoutine disclosure cadence — no material red flags in recent filings.
Recent filings
all on EDGAR ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗8-KPeriod ending 2026-06-042026-06-04open ↗4Period ending 2026-05-132026-05-14open ↗
Frequently asked
- Is ORTHOPEDIATRICS CORP (KIDS) a buy?
- KIDS currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 15.4% YoY; but unprofitable (net margin -16.8%).
- What is ORTHOPEDIATRICS CORP's quality score?
- KIDS scores 51.50980392156862/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001425450, latest 10-Q filed 2026-05-01) · EODHD · as of 6/26/2026, 7:40:18 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.